<DOC>
	<DOCNO>NCT00238758</DOCNO>
	<brief_summary>The purpose study determine whether omega-3 polyunsaturated fatty acid effective monotherapy depression .</brief_summary>
	<brief_title>A Study Omega-3 Treatment Major Depression</brief_title>
	<detailed_description>The study 6 week , parallel-group , double-blind randomize controlled trial efficacy Omega-3 monotherapy depression . People age 21-65 major depression currently antidepressant plan take antidepressant next 14 week recruit . Participants randomly allocate receive Omega-3 ( fish oil ) placebo ( paraffin oil ) 6 week . Participants follow weekly ask rate mood daily 6 week study period . Blood sample take pre post treatment measure change omega-3 level . At end 6 week participant receive 8 week supply omega-3 .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Must meet DSM IV criterion nonpsychotic major depression last least 6 week dysthymia . Must care mental health practitioner . Must able give inform consent . Must able attend Black Dog Institute . Unsuccessful treatment 2 antidepressant medication ( therapeutically adequate dos duration . History psychosis mania/hypomania personality disorder . NonEnglish speaking otherwise unable provide historical information . Having take Omega3 dietary supplement last 3 month . Taking antidepressant medication depression . History allergy n3 PUFA supplement , finfish shellfish . Pregnancy , breast feeding planning become pregnant course study . Postnatal depression . Current drug alcohol abuse dependence history abuse dependence last 12 month . Unstable thyroid function Hepatic renal impairment medical condition may interfere absorption metabolism omega3 polyunsaturated fatty acid . Coagulopathy anticoagulant treatment . Patients , investigator 's judgment pose current serious suicidal safety risk , patient likely able comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Mood Disorder</keyword>
</DOC>